AngioJet technology creates a vacuum for fast and effective removal of a thrombus.
The water jet vacuum pulls the thrombus into the catheter where it is pulverized and evacuated from the body.
With combination therapy, a catheter infuses medication into the thrombus to soften it.
With combination therapy, once the thrombus is softened, AngioJet technology removes the clot from the body. Learn more
AngioJet® Mechanical Thrombectomy
AngioJet mechanical thrombectomy is the only FDA-cleared endovascular treatment option that actually removes a thrombus associated with DVT from the body. This procedure quickly restores blood flow and resolves symptoms within minutes.
With AngioJet technology, a thin, flexible catheter is inserted into the thrombus. High-speed water jets create a vacuum to pull the thrombus into the catheter where the jets break it into tiny fragments. The fragments of thrombus are propelled back through the catheter and evacuated from the body.
Some of the possible benefits of using mechanical thrombectomy to remove thrombus include:
- Rapid restoration of blood flow
- Removal of thrombus from the body
- Quick resolution of symptoms
- Potential for eliminating or reducing amount and duration of medications
- Compatibility with other therapies if necessary
Potential complications of mechanical thrombectomy include damage to red blood cells (hemolysis), which can harm the kidneys and/or pancreas.
AngioJet Mechanical Thrombectomy
Combined with Thrombolytics
A therapy called pharmacomechanical thrombectomy combines catheter-delivered thrombolytics and mechanical thrombectomy. With this treatment option, the mechanical thrombectomy system is used to power-infuse a thrombolytic agent directly into the thrombus. After approximately 15-20 minutes, the thrombus is softened, facilitating its rapid removal by the system.
Recent medical publications on pharmacomechanical thrombectomy have reported the advantages of faster symptom relief, less procedure time, reduced time in the ICU, shorter hospital stays and subsequent cost savings.3-6
3. Bush RL, et al. Pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis: Safety and feasibility study. Journal of Vascular Surgery 2004; 40:965-70.
4. Cynamon J, et al. A new method for aggressive management of deep vein thrombosis: retrospective study of the power pulse technique. Journal of Vascular and Interventional Radiology 2006; 17:1043-49.
5. Garcia M, et al. ATTACK-DVT: AngioJet and TPA thrombolysis: A closer look at combined therapy for the treatment of DVT. Presented at Society of Interventional Radiology Conference, Seattle, WA, 2007.
6. Lin PH, et al. Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis. American Journal of Surgery 2006; 192:782-88.
Learn more about combination therapy for removal of thrombus associated with DVT.
AngioJet is a trademark of MEDRAD, INC.
